Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

82.56 -4.35 (-5.01%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 887,941
Open 86.60
Bid (Size) 82.60 (10)
Ask (Size) 84.56 (1)
Prev. Close 86.91
Today's Range 82.40 - 87.02
52wk Range 25.32 - 117.75
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025
From GeneDx
Via Business Wire
Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday
Via Benzinga

Performance

YTD
+3.7%
+3.7%
1 Month
+18.8%
+18.8%
3 Month
-10.9%
-10.9%
6 Month
-7.6%
-7.6%
1 Year
+163.9%
+163.9%

More News

Read More
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains
Via MarketBeat
Expert Outlook: GeneDx Holdings Through The Eyes Of 4 Analysts
Via Benzinga
Why GeneDX Stock Surged Higher This Week
Via The Motley Fool
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics
From GeneDx
Via Business Wire
Why GeneDx, An IBD 50 Stock, Has Skyrocketed 34% Over The Past Two Days
Via Investor's Business Daily
Carnival Posts Better-Than-Expected Earnings, Joins Liminatus Pharma, Coinbase Global, Uber And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual Disability
From GeneDx
Via Business Wire
Galatea Bio and Fabric Genomics Partner to Deliver Comprehensive Genetic Testing for Common Diseases
From GeneDx
Via Business Wire
GENEDX ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Rosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation – WGS
From The Rosen Law Firm, P.A.
Via Business Wire
WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
GeneDx to Participate in Upcoming Investor Conferences
From GeneDx
Via Business Wire
GeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at Scale
From GeneDx
Via Business Wire
Analyst Expectations For GeneDx Holdings's Future
Via Benzinga
This National Vision Holdings Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday
Via Benzinga
GeneDx Announces Completion of Fabric Genomics Acquisition
From GeneDx
Via Business Wire
Why Investors Were Avoiding GeneDx Holdings Stock This Week
Via The Motley Fool
Retail Buzz Swirls Around GeneDx As Shares Sink 43% Despite Earnings Beat
Via Stocktwits
Wednesday's session: top gainers and losers
Via Chartmill
Top stock movements in today's session.
Via Chartmill

Frequently Asked Questions

Is GeneDx Holdings Corp. - Class A Common Stock publicly traded?
Yes, GeneDx Holdings Corp. - Class A Common Stock is publicly traded.
What exchange does GeneDx Holdings Corp. - Class A Common Stock trade on?
GeneDx Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeneDx Holdings Corp. - Class A Common Stock?
The ticker symbol for GeneDx Holdings Corp. - Class A Common Stock is WGS on the Nasdaq Stock Market
What is the current price of GeneDx Holdings Corp. - Class A Common Stock?
The current price of GeneDx Holdings Corp. - Class A Common Stock is 82.56
When was GeneDx Holdings Corp. - Class A Common Stock last traded?
The last trade of GeneDx Holdings Corp. - Class A Common Stock was at 07/11/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.